Memory Decline and Its Reversal in Aging and Neurodegeneration Involve miR-183/96/182 Biogenesis.


Journal

Molecular neurobiology
ISSN: 1559-1182
Titre abrégé: Mol Neurobiol
Pays: United States
ID NLM: 8900963

Informations de publication

Date de publication:
May 2019
Historique:
received: 11 05 2018
accepted: 09 08 2018
pubmed: 22 8 2018
medline: 14 8 2019
entrez: 22 8 2018
Statut: ppublish

Résumé

Aging is characterized by progressive memory decline that can lead to dementia when associated with neurodegeneration. Here, we show in mice that aging-related memory decline involves defective biogenesis of microRNAs (miRNAs), in particular miR-183/96/182 cluster, resulting from increased protein phosphatase 1 (PP1) and altered receptor SMAD (R-SMAD) signaling. Correction of the defect by miR-183/96/182 overexpression in hippocampus or by environmental enrichment that normalizes PP1 activity restores memory in aged animals. Regulation of miR-183/96/182 biogenesis is shown to involve the neurodegeneration-related RNA-binding proteins TDP-43 and FUS. Similar alterations in miR-183/96/182, PP1, and R-SMADs are observed in the brains of patients with amyotrophic lateral sclerosis (ALS) or frontotemporal lobar degeneration (FTLD), two neurodegenerative diseases with pathological aggregation of TDP-43. Overall, these results identify new mechanistic links between miR-183/96/182, PP1, TDP-43, and FUS in age-related memory deficits and their reversal.

Identifiants

pubmed: 30128653
doi: 10.1007/s12035-018-1314-3
pii: 10.1007/s12035-018-1314-3
doi:

Substances chimiques

MicroRNAs 0
RNA-Binding Protein FUS 0
Smad Proteins 0
Protein Phosphatase 1 EC 3.1.3.16

Types de publication

Journal Article

Langues

eng

Pagination

3451-3462

Références

Nature. 2002 Aug 29;418(6901):970-5
pubmed: 12198546
Nat Rev Neurosci. 2004 Feb;5(2):87-96
pubmed: 14735112
FEBS Lett. 2004 Jun 1;567(1):121-8
pubmed: 15165904
J Neurol. 2004 Sep;251(9):1098-104
pubmed: 15372253
Neurology. 2005 Jul 12;65(1):62-7
pubmed: 16009886
Neurology. 2005 Aug 23;65(4):586-90
pubmed: 16116120
Am J Pathol. 2006 May;168(5):1598-607
pubmed: 16651626
Science. 2006 Oct 6;314(5796):130-3
pubmed: 17023659
Nat Protoc. 2008;3(6):1101-8
pubmed: 18546601
Nature. 2008 Jul 3;454(7200):56-61
pubmed: 18548003
Brain. 2009 Nov;132(Pt 11):2922-31
pubmed: 19674978
J Mol Neurosci. 2010 Jan;40(1-2):47-55
pubmed: 19711202
J Neurosci. 2009 Oct 14;29(41):13079-89
pubmed: 19828821
Eur J Neurol. 2010 Jan;17(1):103-10
pubmed: 19874396
Nature. 2010 Mar 25;464(7288):529-35
pubmed: 20336135
Mol Cell. 2010 Aug 13;39(3):373-84
pubmed: 20705240
FEBS Lett. 2012 Jul 4;586(14):1906-12
pubmed: 22306316
Proc Natl Acad Sci U S A. 2012 Feb 28;109(9):3347-52
pubmed: 22323604
Nature. 2012 Feb 29;483(7388):222-6
pubmed: 22388814
J Gerontol A Biol Sci Med Sci. 2012 Jun;67(7):741-6
pubmed: 22522509
PLoS One. 2012;7(7):e40028
pubmed: 22844398
BMC Neurol. 2012 Dec 05;12:151
pubmed: 23217188
EMBO J. 2012 Dec 12;31(24):4502-10
pubmed: 23232809
Genes Dev. 2012 Dec 15;26(24):2690-5
pubmed: 23249733
Sci Transl Med. 2013 Aug 28;5(200):200ra115
pubmed: 23986399
Mol Neurobiol. 2013 Dec;48(3):952-63
pubmed: 24113842
Methods Mol Biol. 2014;1095:87-93
pubmed: 24166304
PLoS One. 2014 Mar 04;9(3):e90449
pubmed: 24595038
Cell Death Dis. 2014 Mar 13;5:e1116
pubmed: 24625975
Am J Physiol Cell Physiol. 2014 Aug 15;307(4):C314-9
pubmed: 24871856
BMC Psychiatry. 2014 May 05;14:129
pubmed: 24886353
Hum Mol Genet. 2014 Dec 1;23(23):6318-31
pubmed: 25055867
Biochem Biophys Res Commun. 1989 Mar 31;159(3):871-7
pubmed: 2539153
Behav Brain Res. 2015;287:15-26
pubmed: 25813747
Sci Rep. 2015 May 29;5:10614
pubmed: 26024049
Nucleic Acids Res. 2015 Oct 15;43(18):8990-9005
pubmed: 26261209
Prog Neuropsychopharmacol Biol Psychiatry. 2016 Feb 4;65:96-103
pubmed: 26368940
Biochem Pharmacol. 2016 Mar 15;104:1-7
pubmed: 26626188
Prog Neuropsychopharmacol Biol Psychiatry. 2017 Feb 6;73:79-86
pubmed: 27117821
Nat Commun. 2016 Aug 25;7:12594
pubmed: 27558292
Neurobiol Learn Mem. 2017 Mar;139:63-68
pubmed: 28039088
Sci Rep. 2017 Aug 11;7(1):7910
pubmed: 28801686
Cereb Cortex. 2018 Sep 1;28(9):3309-3321
pubmed: 28968688
Sci Rep. 2018 Jan 26;8(1):1678
pubmed: 29374200

Auteurs

Ali Jawaid (A)

Laboratory of Neuroepigenetics, Neuroscience Center Zürich, University of Zurich (UZH) and Swiss Federal Institute of Technology (ETH), Zurich, Switzerland.

Bisrat T Woldemichael (BT)

Laboratory of Neuroepigenetics, Neuroscience Center Zürich, University of Zurich (UZH) and Swiss Federal Institute of Technology (ETH), Zurich, Switzerland.
Icahn school of medicine at Mount Sinai, New York, USA.

Eloïse A Kremer (EA)

Laboratory of Neuroepigenetics, Neuroscience Center Zürich, University of Zurich (UZH) and Swiss Federal Institute of Technology (ETH), Zurich, Switzerland.

Florent Laferriere (F)

Institute of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.

Niharika Gaur (N)

Laboratory of Neuroepigenetics, Neuroscience Center Zürich, University of Zurich (UZH) and Swiss Federal Institute of Technology (ETH), Zurich, Switzerland.

Tariq Afroz (T)

Institute of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.

Magdalini Polymenidou (M)

Institute of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.

Isabelle M Mansuy (IM)

Laboratory of Neuroepigenetics, Neuroscience Center Zürich, University of Zurich (UZH) and Swiss Federal Institute of Technology (ETH), Zurich, Switzerland. mansuy@hifo.uzh.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH